Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia - PubMed (original) (raw)

doi: 10.1007/s00415-004-0447-7.

Christoph Lichy, Gottfried Rudofsky, Per M Humpert, Just Genius, Tuan-Dong Si, Christof Dörfer, Armin J Grau, Andreas Hamann, Werner Hacke, Peter P Nawroth, Angelika Bierhaus

Affiliations

• PMID: 15258789
• DOI: 10.1007/s00415-004-0447-7

Lack of association between polymorphisms of the toll-like receptor 4 gene and cerebral ischemia

Peter Reismann et al. J Neurol. 2004 Jul.

Abstract

Toll-like receptor-4 (TLR4), an important mediator of the innate immune response, is expressed in atherosclerotic lesions. The common single nucleotide exchange (Asp299Gly) of the TLR4 gene has been previously reported to impair TLR4 function and to be associated with a decreased risk of carotid atherosclerosis. Therefore, we aimed to detect the potential impact of TLR4 genotypes on the risk of cerebral ischemia. We studied the prevalence of two common polymorphisms of the TLR4 gene (Asp299Gly and Thr399Ile) in 3 independent study populations: (1.) in a cross-sectional study including 769 patients either with type 1 or type 2 diabetes mellitus, of whom 56 (7.2%) had a history of cerebral ischemia (study 1), (2.) a case-control study (study 2) including 128 consecutive patients with cerebral ischemia, mean age 60 +/- 10.9 years and 139 control subjects, and (3.) a case-control study (study 3) including 171 young adults aged < 50 years with cerebral ischemia and 204 control individuals. In all subjects, Asp299Gly and Thr399Ile were detected by restriction length analysis. The prevalence of the TLR4 genotypes was essentially the same between patients with cerebral ischemia and control subjects in all 3 study populations. Furthermore, there was also no association with the subgroup of atherosclerotic stroke in both case-control studies populations. Although TLR4 polymorphisms are associated with a decreased risk of carotid atherosclerotic lesions, our findings indicate that they do not influence the prevalence of cerebral ischemia. This implies that the Asp299Gly TLR4-allele might have a protective role in carotid atherosclerosis, but not in cerebral ischemia.

PubMed Disclaimer

Similar articles

• The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
  Brand S, Staudinger T, Schnitzler F, Pfennig S, Hofbauer K, Dambacher J, Seiderer J, Tillack C, Konrad A, Crispin A, Göke B, Lohse P, Ochsenkühn T. Brand S, et al. Inflamm Bowel Dis. 2005 Jul;11(7):645-52. doi: 10.1097/01.mib.0000168372.94907.d2. Inflamm Bowel Dis. 2005. PMID: 15973118
• Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.
  Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, Lamotte M, Lebret D, Ollivier V, de Prost D. Ameziane N, et al. Arterioscler Thromb Vasc Biol. 2003 Dec;23(12):e61-4. doi: 10.1161/01.ATV.0000101191.92392.1D. Epub 2003 Oct 16. Arterioscler Thromb Vasc Biol. 2003. PMID: 14563652
• The toll-like receptor 4 Asp299Gly variant: no influence on LPS responsiveness or susceptibility to pulmonary tuberculosis in The Gambia.
  Newport MJ, Allen A, Awomoyi AA, Dunstan SJ, McKinney E, Marchant A, Sirugo G. Newport MJ, et al. Tuberculosis (Edinb). 2004;84(6):347-52. doi: 10.1016/j.tube.2004.02.001. Tuberculosis (Edinb). 2004. PMID: 15525557
• Toll like receptor 4 gene Asp299Gly polymorphism increases the risk of diabetic microvascular complications: a meta analysis.
  Zhang Y, Li H, Wang C, Lv H, Fu S. Zhang Y, et al. Diabetol Metab Syndr. 2022 Jun 7;14(1):79. doi: 10.1186/s13098-022-00849-2. Diabetol Metab Syndr. 2022. PMID: 35672795 Free PMC article. Review.
• Stroke Risk Factors, Genetics, and Prevention.
  Boehme AK, Esenwa C, Elkind MS. Boehme AK, et al. Circ Res. 2017 Feb 3;120(3):472-495. doi: 10.1161/CIRCRESAHA.116.308398. Circ Res. 2017. PMID: 28154098 Free PMC article. Review.

Cited by

• Association of Toll-like receptor 2 polymorphisms with National Institute of Health Stroke Scale scores of ischemic stroke patients.
  Park HJ, Kim SK, Yun DH, Kim DH, Chon J, Kim JW, Chung JH. Park HJ, et al. J Mol Neurosci. 2012 Mar;46(3):536-40. doi: 10.1007/s12031-011-9640-1. Epub 2011 Sep 2. J Mol Neurosci. 2012. PMID: 21887520
• Polyoxygenated cholesterol ester hydroperoxide activates TLR4 and SYK dependent signaling in macrophages.
  Choi SH, Yin H, Ravandi A, Armando A, Dumlao D, Kim J, Almazan F, Taylor AM, McNamara CA, Tsimikas S, Dennis EA, Witztum JL, Miller YI. Choi SH, et al. PLoS One. 2013 Dec 23;8(12):e83145. doi: 10.1371/journal.pone.0083145. eCollection 2013. PLoS One. 2013. PMID: 24376657 Free PMC article.
• Toll-like receptors and ischemic brain injury.
  Gesuete R, Kohama SG, Stenzel-Poore MP. Gesuete R, et al. J Neuropathol Exp Neurol. 2014 May;73(5):378-86. doi: 10.1097/NEN.0000000000000068. J Neuropathol Exp Neurol. 2014. PMID: 24709682 Free PMC article. Review.
• Cerebral ischemic damage in diabetes: an inflammatory perspective.
  Shukla V, Shakya AK, Perez-Pinzon MA, Dave KR. Shukla V, et al. J Neuroinflammation. 2017 Jan 23;14(1):21. doi: 10.1186/s12974-016-0774-5. J Neuroinflammation. 2017. PMID: 28115020 Free PMC article. Review.
• Toll-like receptor 4 polymorphisms in Saudi population with cardiovascular diseases.
  Semlali A, Al Mutairi M, Oqla Alanazi I, Awad Aljohi H, Reddy Parine N, Alhadheq A, Al-Jafari AA, Mobeirek AF, Al Amri A, Shaik JP, Filali FZ, Alanazi M. Semlali A, et al. Mol Genet Genomic Med. 2019 Sep;7(9):e852. doi: 10.1002/mgg3.852. Epub 2019 Jul 21. Mol Genet Genomic Med. 2019. PMID: 31328431 Free PMC article.

References

1. 1. Stroke. 2003 Feb;34(2):418-21 - PubMed
2. 1. Biotechniques. 2001 Jul;31(1):22-4 - PubMed
3. 1. Stroke. 1993 Jan;24(1):35-41 - PubMed
4. 1. J Immunol. 2002 Jan 15;168(2):554-61 - PubMed
5. 1. N Engl J Med. 2002 Jul 18;347(3):185-92 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer